Your browser doesn't support javascript.
loading
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.
Liu, Yingjun; Pertinez, Henry; Davies, Geraint R; Gillespie, Stephen H; Coates, Anthony R; Hu, Yanmin.
Afiliação
  • Liu Y; Institute for Infection and immunity, St. George's, University of London, London, United Kingdom.
  • Pertinez H; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Davies GR; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Gillespie SH; School of Medicine, University of St. Andrews, St. Andrews, United Kingdom.
  • Coates AR; Institute for Infection and immunity, St. George's, University of London, London, United Kingdom.
  • Hu Y; Institute for Infection and immunity, St. George's, University of London, London, United Kingdom ymhu@sgul.ac.uk.
Antimicrob Agents Chemother ; 62(7)2018 07.
Article em En | MEDLINE | ID: mdl-29661869
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Etambutol / Moxifloxacina / Isoniazida / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Etambutol / Moxifloxacina / Isoniazida / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article